Season 2 of Common Side Effects may be confirmed

The trailer for Episode 10 of Common Side Effects may have hinted at plans for a second season, even before the season finale airs. The popular Adult Swim series follows two former lab partners who discover a magical mushroom. This mushroom can heal many ailments, but it puts them at odds with the DEA, big pharmaceutical companies, and other powerful interests. In the season finale, the lead character, Marshall, is presumed dead after an FBI raid goes wrong. The episode's description mentions "tragic consequences," raising concerns among fans. However, many believe it’s unlikely that the show would kill off its main character this early. The preview suggests a possibility of hope for Marshall. Fans are eagerly speculating about his fate, with comments on social media expressing hope that he survives. As the finale approaches on March 30, excitement for a potential second season is also growing. Although the show has not yet been officially renewed, writer Steve Hely shared that the team recently pitched ideas for Season 2 to Adult Swim. The network seemed interested, but they are likely waiting to see how the season finale performs. Fans remain optimistic, given that many Adult Swim series typically continue beyond their first season.